1. MET gene amplification is a mechanism of resistance to entrectinib in ROS1+ NSCLC. Issue 21 (13th September 2022) Authors: Tyler, Logan C.; Le, Anh T.; Chen, Nan; Nijmeh, Hala; Bao, Liming; Wilson, Timothy R.; Chen, David; Simmons, Brian; Turner, Kristen M.; Perusse, Dean; Kasibhatla, Shailaja; Christiansen, Jason; Dudek, Arkadiusz Z.; Doebele, Robert C. Journal: Thoracic cancer Issue: Volume 13:Issue 21(2022) Page Start: 3032 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗